EHR costs cited as 3 hospitals, parent company file for bankruptcy

Three Mississippi hospitals and their parent company have filed for bankruptcy—identifying electronic health record (EHR) costs and declining revenues as primary reasons.

According to a report by the Plainview Daily Herald, nonprofit health system Curae Health recently filed for Chapter 11 bankruptcy reorganization in Nashville, Tennessee. Three of the company’s Mississippi hospitals—Gilmore Memorial Hospital, Panola Medical Center and Northwest Mississippi Regional Medical Center—are also seeking bankruptcy.

In the report, Curae Health CEO Stephen Clapp said the move was brought on by declining revenues and “higher-than-expected costs” for EHRs at the hospitals. The company was also about $70 million in debt.

“Clapp added that past revenue and profits were high enough when Curae bought the hospitals in 2017 to pay off the money the company borrowed," the report said. "But he said revenue declined and the hospitals faced higher-than-expected costs for electronic health records. He said the company saw a cash crunch, with vendors demanding payment for lagging bills, which sparked the bankruptcy filing."

To read the full report, click the link below.

""

Danielle covers Clinical Innovation & Technology as a senior news writer for TriMed Media. Previously, she worked as a news reporter in northeast Missouri and earned a journalism degree from the University of Illinois at Urbana-Champaign. She's also a huge fan of the Chicago Cubs, Bears and Bulls. 

Around the web

A string of executive orders from the White House created serious concerns among radiologists and other healthcare providers throughout the United States. The American College of Radiology issued a statement to help guide its members through the chaos. 

Bridgefield Capital, founded in 2015, has previously invested in such popular brands as Cirque Du Soleil, Del Monte and Quiksilver. This transaction is expected to be completed in the second half of 2025. 

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it.